Salient Private Client’s Oracle ORCL Stock Holding History

Salient Private Client’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,080	Closed	-$477K	–	131
2017 Q4	$477K	Buy	+10,080	New	+$494K	0.1%	89

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Eagle Capital Management (New York) New York $29.8B AUM 12.13% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Salient Private Client's ORCL Position: Q1 2018 in Review

Salient Private Client sold out of Oracle (ORCL) in Q1 2018, closing a stake of 10,080 shares — an estimated $477K sold.

Salient Private Client first reported a position in ORCL in Q4 2017 and held it in 1 quarter. The position peaked at $477K in Q4 2017. 1,752 funds tracked by Wall St. Rank hold ORCL as of Q1 2018.

Salient Private Client reported no remaining Oracle position as of Q1 2018 after selling out during the quarter.
Salient Private Client sold 10,080 Oracle shares in Q1 2018, an estimated $477K.
Salient Private Client first reported a position in Oracle in Q4 2017 and held it in 1 quarter.
Salient Private Client's Oracle position peaked at $477K in Q4 2017.
1,752 funds tracked by Wall St. Rank held Oracle as of Q1 2018.

Based on Salient Private Client's 13F filing for Q1 2018, filed 2 May 2018.